10月22日新股申购 (共1) | | | 丹娜生物(北交所,920 | | --- | --- | --- | | 申购代码 | | 920009 | | 发行价格 | | 17.10元 顶格F | | 总市值 | | l | | 发行市盈率 | | 11.75 行业 | | 同业可比公司 | | 浩欧博 同业公司 | | | | 科美诊断 动态市盈率 | | | | 透景生命 | | | | 试剂产品: 90.41%; | | 主营构成 | 仪器产品: 6.05%; | | | | 其他：3.54% | | | | | 1、公司致力于侵袭性真菌病血清学早期诊断及其 | | | | 发创新，在细分领域市场中占据重要地位。 | | 业务及亮点 | | 2、公司推出"5G+真菌病血清学联合检测方案" | | | 7 + / キに ロキ に イ ー ホー ホーム レビ ( | | | | 马可波罗(深市主板,00 | | --- | --- | | 发行价格 | 13.75元 | | 阳签率 | 0.03% 询价! | | 总市值 | 164.3亿 | | 发行市盈率 | 14.27 行业 | | 1、 | 公司 ...

Core Viewpoint - The company Marco Polo is a leading player in the domestic ceramic tile industry, with a strong brand value and a focus on expanding into related home furnishing products and innovative new offerings [2][3]. Group 1: Company Overview - The company is listed on the Shenzhen Main Board with the stock code 001386 and has an issuance price of 13.75 yuan [2]. - The total market capitalization of the company is 14.79 billion yuan, with an industry P/E ratio of 14.27 [2]. - The main business composition includes 98.14% glazed tiles and 1.86% unglazed tiles [2]. Group 2: Financial Performance - The company reported revenues of 7.324 billion yuan in 2024, reflecting a decrease of 17.93% compared to the previous year [3]. - The net profit attributable to the parent company was 8.925 billion yuan in 2023, showing an increase of 3.05% from 2022, which had a net profit of 8.661 billion yuan, down by 7.52% [3]. Group 3: Business Highlights and Future Plans - The company is gradually expanding into finished furniture and related home scenarios while actively developing new products, including curved electric ceramic tiles and 2.5mm ultra-thin high-strength decorative ceramic slabs [2]. - The fundraising will be directed towards upgrading the intelligent ceramic home industry park and green intelligent manufacturing projects in Jiangxi and Guangdong [3].